Correspondence to Dr Parco M Siu, The University of Hong Kong, Hong Kong, 999077, Hong Kong; pmsiu{at}hku.hk Data sources Embase, MEDLINE, PsycINFO, Cochrane Library, Web of Science, Scopus and ...

Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, ...

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...

Our FDA: Drug & Device Team examines the FDA’s new draft guidance that allows biosimilar developers to rely more on analytical and pharmacokinetic data, reducing the need for costly and time-consuming ...

Students majoring and minoring in CRES are prepared to enter the workforce as informed citizens in a diverse and challenging society.

The U.S. Food and Drug Administration (FDA) issued new draft guidance on October 29, 2025, proposing what it said were “major updates to simplify biosimilarity studies and reduce unnecessary clinical ...

Mental illness is a significant cause of morbidity and mortality globally, with its burden continually increasing. The World Health Organization emphasizes the urgent need for accessible and scalable ...